Product
Help
Pricing
About
Jobs
Log in
Get started
Work
Add to collection
Rifaximin pharmacology and clinical implications
HTML
Details
Locations
Year:
2009
Type:
review
Source:
Expert Opinion on Drug Metabolism & Toxicology
DOI:
10.1517/17425250902973695
Authors:
Veronica Ojetti,
Ernesto Cristiano Lauritano,
Federico Barbaro,
Alessio Migneco,
Maria Elena Ainora,
Luigi Fontana,
Maurizio Gabrielli,
Antonio Gasbarrini
show all 8
Institutions:
Università Cattolica del Sacro Cuore,
Agostino Gemelli University Polyclinic,
Washington University in St. Louis
Language:
English
Topic:
Gut microbiota and health
Subfield:
Molecular Biology
Field:
Biochemistry, Genetics and Molecular Biology
Domain:
Life Sciences
Keywords:
rifaximin,
rifamycin,
antibacterial mechanism,
RNA polymerase inhibition,
gut microbiota,
hepatic encephalopathy,
small intestinal bacterial overgrowth,
inflammatory bowel disease,
diverticular disease,
antibiotic resistance,
drug safety
show all 11
SDG:
Good health and well-being
Open Access status:
closed
OpenAlex ID:
W2036426721
FWCI:
0.346
Cites:
62
Cited by:
74
Related to:
9